![](https://www.lachmanconsultants.com/wp-content/uploads/2020/04/iStock-1048316790.jpg)
More PSGs Issued by OGD
Yesterday, the Office of Generic Drugs released twenty-four new and thirteen revised Product Specific Guidances (PSGs) with recommendations for conducting studies necessary to establish bioequivalence between test and reference products. Of course, the revisions might spell trouble for applicants that have already commenced testing according to the original guidances, but this has been a bone […]